Cipla Limited (NSE:CIPLA)
India · Delayed Price · Currency is INR 1,565.80
+7.10 (0.46%)
Oct 16, 2025, 1:30 PM IST
Cipla Market Cap
Cipla has a market cap or net worth of 1.26 trillion as of October 15, 2025. Its market cap has decreased by -3.87% in one year.
Market Cap
1.26T
Enterprise Value
1.16T
Revenue
274.80B
Ranking
n/a
PE Ratio
23.36
Stock Price
1,565.80
Market Cap Chart
Since May 30, 1996, Cipla's market cap has increased from 1.51B to 1.26T, an increase of 83,077.82%. That is a compound annual growth rate of 25.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 1,259.06B | 1.96% |
| Dec 31, 2024 | 1,234.84B | 22.72% |
| Dec 29, 2023 | 1,006.20B | 15.87% |
| Dec 30, 2022 | 868.37B | 14.01% |
| Dec 31, 2021 | 761.69B | 15.19% |
| Dec 31, 2020 | 661.25B | 71.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,003.05B |
| Divi's Laboratories | 1,740.41B |
| Apollo Hospitals Enterprise | 1,102.97B |
| Mankind Pharma | 1,008.16B |
| Zydus Lifesciences | 1,001.71B |
| Fortis Healthcare | 826.79B |
| Aurobindo Pharma | 660.26B |
| Alkem Laboratories | 656.71B |